Similar articles for PMID: 17668880

Year	Number of Results
1995	1
1998	3
2000	5
2001	5
2002	9
2003	6
2004	15
2005	26
2006	22
2007	34
2008	20
2009	19
2010	23
2011	22
2012	11
2013	13
2014	16
2015	16
2016	11
2017	5
2018	6
2019	8
2020	2
2021	2
2024	0

1

Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.

Schaefer M, Hinzpeter A, Mohmand A, Janssen G, Pich M, Schwaiger M, Sarkar R, Friebe A, Heinz A, Kluschke M, Ziemer M, Gutsche J, Weich V, Halangk J, Berg T. Schaefer M, et al. Hepatology. 2007 Oct;46(4):991-8. doi: 10.1002/hep.21791. Hepatology. 2007. PMID: 17668880 Clinical Trial.

2

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.

Schaefer M, Schmidt F, Folwaczny C, Lorenz R, Martin G, Schindlbeck N, Heldwein W, Soyka M, Grunze H, Koenig A, Loeschke K. Schaefer M, et al. Hepatology. 2003 Feb;37(2):443-51. doi: 10.1053/jhep.2003.50031. Hepatology. 2003. PMID: 12540795

3

Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects.

Schaefer M, Mauss S. Schaefer M, et al. Curr Drug Abuse Rev. 2008 Jun;1(2):177-87. doi: 10.2174/1874473710801020177. Curr Drug Abuse Rev. 2008. PMID: 19630716 Review.

4

Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin.

Yu JW, Wang GQ, Sun LJ, Li XG, Li SC. Yu JW, et al. J Gastroenterol Hepatol. 2007 Jun;22(6):832-6. doi: 10.1111/j.1440-1746.2007.04904.x. J Gastroenterol Hepatol. 2007. PMID: 17565637

5

Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection.

Alvarez-Uria G, Day JN, Nasir AJ, Russell SK, Vilar FJ. Alvarez-Uria G, et al. Liver Int. 2009 Aug;29(7):1051-5. doi: 10.1111/j.1478-3231.2008.01958.x. Liver Int. 2009. PMID: 19580634

6

A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.

Neri S, Bertino G, Petralia A, Giancarlo C, Rizzotto A, Calvagno GS, Mauceri B, Abate G, Boemi P, Di Pino A, Ignaccolo L, Vadalà G, Misseri M, Maiorca D, Mastrosimone G, Judica A, Palermo F. Neri S, et al. J Clin Gastroenterol. 2010 Oct;44(9):e210-7. doi: 10.1097/MCG.0b013e3181d88af5. J Clin Gastroenterol. 2010. PMID: 20838237 Clinical Trial.

7

De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C.

Martín-Santos R, Díez-Quevedo C, Castellví P, Navinés R, Miquel M, Masnou H, Soler A, Ardevol M, García F, Galeras JA, Planas R, Solà R. Martín-Santos R, et al. Aliment Pharmacol Ther. 2008 Feb 1;27(3):257-65. doi: 10.1111/j.1365-2036.2007.03568.x. Epub 2007 Nov 6. Aliment Pharmacol Ther. 2008. PMID: 17988237 Free article.

8

Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C.

Huang CF, Yang JF, Dai CY, Huang JF, Hou NJ, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL, Yu ML. Huang CF, et al. J Infect Dis. 2010 Mar;201(5):751-9. doi: 10.1086/650470. J Infect Dis. 2010. PMID: 20102281

9

Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy.

Sasadeusz JJ, Dore G, Kronborg I, Barton D, Yoshihara M, Weltman M. Sasadeusz JJ, et al. Addiction. 2011 May;106(5):977-84. doi: 10.1111/j.1360-0443.2010.03347.x. Addiction. 2011. PMID: 21205057 Clinical Trial.

10

Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C.

Wang LJ, Chen SW, Chen CK, Yen CL, Chang JJ, Lee TS, Liu CJ, Chen LW, Chien RN. Wang LJ, et al. BMC Psychiatry. 2016 Nov 25;16(1):424. doi: 10.1186/s12888-016-1135-8. BMC Psychiatry. 2016. PMID: 27884134 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

277 results

Results by year